Technology News and Research

RSS

CryoLife files emergency motion for preliminary injunction against Medafor

CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it filed an emergency motion for a preliminary injunction against Medafor, Inc. in the United States District Court for the Northern District of Georgia, Atlanta division. CryoLife contends that Medafor is improperly attempting to terminate the exclusive distribution agreement ("EDA") between the parties, and CryoLife has requested that the Court enjoin Medafor from proceeding with the termination.

31 Mar 2010

FDA grants priority review status for Isotechnika Pharma's voclosporin

Isotechnika Pharma Inc. today announced that the New Drug Application (NDA) for the Company's next generation calcineurin inhibitor, voclosporin, has been accepted for priority review as filed by the U.S. Food and Drug Administration (FDA). The application was submitted by Isotechnika's partner, Lux Biosciences, Inc.

31 Mar 2010

Reverse Medical closes Series-B private equity financing

Reverse Medical Corporation announced today the closing of their Series-B private equity financing. The Company raised $14 million from new investors Wexford Capital, Getz Bros., BioStar Ventures, Early Stage Partners and Emergent Medical Partners.

31 Mar 2010

QRxPharma initiates Phase 1 trial for evaluating PK profiles of morphine, oxycodone CR formulations

QRxPharma announced today initiation of the Company's first Phase 1 trial to evaluate the pharmacokinetic (PK) profiles of experimental controlled-release (CR) morphine and oxycodone formulations that will be incorporated into MoxDuo®CR. MoxDuo®CR contains a fixed 3:2 morphine:oxycodone combination and is intended to be dosed twice daily in patients experiencing chronic pain, an approximately US$7 billion dollar market worldwide.

31 Mar 2010

Vision CRC scientists discover new technology to control myopia

Scientists from the Vision Cooperative Research Centre in Australia today announced that myopia, or short-sightedness, can be controlled with new technology. This ground breaking discovery was based on research conducted by Vision CRC partners - the University of Houston College of Optometry and the Brien Holden Vision Institute, located at the University of New South Wales.

31 Mar 2010

Access Pharmaceuticals, bioRASI sign collaborative agreement to develop Cobalamin oral insulin product

ACCESS PHARMACEUTICALS, INC. signed a collaborative development agreement with bioRASI, LLC, a full-service global CRO specializing in the accelerated development of novel therapeutics, to facilitate clinical development for its Cobalamin™-based oral insulin and other Cobalamin-based products.

31 Mar 2010

Hospira acquires Orchid's injectables formulations business

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has completed the acquisition of the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $400 million.

31 Mar 2010

CLC bio signs partnership agreement with Ion Torrent

CLC bio, the world's leading bioinformatics solution provider, today announced a partnership with Ion Torrent, a new sequencing company started by Dr. Jonathan Rothberg, the founder of 454 Life Sciences. The partnership will ensure that data can directly flow off of the Ion Personal Genome Machine sequencer and into CLC bio's solutions, like CLC Genomics Workbench or CLC Genomics Server.

30 Mar 2010

Ascent Therapeutics is now Anchor Therapeutics

Ascent Therapeutics announced today that it has adopted a new name — Anchor Therapeutics. Anchor Therapeutics reflects the Company's core technology and its commitment to building solid, dependable value for patients, partners and investors via its proprietary platform technology.

30 Mar 2010

Campbell Soup honored for commitment to food allergy safety, awareness and education

Campbell Soup Company was recently honored by the Food Allergy and Anaphylaxis Network for its commitment to food allergy safety, awareness and education.

30 Mar 2010

Investment report on Fonar from InvestorSoup.com

InvestorSoup.com announces an investment report featuring Fonar Corp. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

30 Mar 2010

USPTO issues patent for Incisive Surgical's proprietary INSORB Absorbable Skin Stapling Technology

Incisive Surgical, Inc. today announced that the U.S. Patent and Trademark office has issued the company a patent for its proprietary INSORB® Absorbable Skin Stapling Technology. The patent broadly covers the wound closure stapling apparatus.

30 Mar 2010

Bayshore Home Health deploys WinMagic's SecureDoc full-disk encryption software

Bayshore Home Health, Canada's largest provider of home and community health care services, is installing WinMagic's SecureDoc full-disk encryption software on all laptops and tablets used by the company, including those utilized by clinical managers and nurses.

30 Mar 2010

MedBuild receives MBI's 2010 Awards of Distinction for Nash Memorial Hospital Project

Modular Building Institute has named MedBuild, a healthcare division of ModSpace, first-place winner for their 2010 Awards of Distinction. MBI gave MedBuild top honors in its permanent healthcare category for its construction of the patient-ready imaging suite at Nash General Hospital in Rocky Mount, N.C.

30 Mar 2010

Ohio Board of Pharmacy approves CPSI's CPOE, E-MAR and Pharmacy applications

Computer Programs and Systems, Inc., a leading provider of healthcare information technology to community and specialty hospitals, announced today that the Computerized Physician Order Entry (CPOE), Electronic Medication Administration Record (E-MAR) and Pharmacy applications of the CPSI System have achieved "approvable" status from the Ohio Board of Pharmacy. To achieve "approvable" status, CPSI worked with the Board to enhance the security of CPSI's medication management solutions and validate compliance with the Board's standards for the integration of positive caregiver identification.

30 Mar 2010

Study suggests two distinct versions of multiple sclerosis

There may be two distinct versions of multiple sclerosis, a study in both animal models and human blood samples suggests. What's more, a patient's responsiveness to the most popular first-line drug for this episodic and all-too-often recurring autoimmune condition seems to depend on which version that patient has.

30 Mar 2010

Irvine Scientific's Vit Kit- Freeze, Vit Kit- Thaw and Oil for Embryo Culture receive CE mark approval

Irvine Scientific, a leader in Assisted Reproductive Technology (ART), announced today it received CE mark approval for its Vit Kit®- Freeze, Vit Kit®- Thaw and Oil for Embryo Culture. This news accompanies the recent announcement of CE mark approval for a number of other media for ART from Irvine Scientific.

30 Mar 2010

A-Life Medical renews extensive contract for CAC services with Associated Billing Services

A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services to the healthcare industry, announced today the renewal of an extensive contract with Associated Billing Services, Inc. Associated Billing Services provides medical billing and accounts receivable management services throughout Arizona. The company has worked with A-Life Medical for four years.

30 Mar 2010

VECTRA X3 3D Imaging System now available at Staten Island Special Surgery

Probably most known for the Staten Island Ferry, New York City's fifth and often "Forgotten Borough" does not possess a reputation for being a leading destination for cutting-edge medical procedures. That is, until now. This month, prominent Manhattan plastic surgeon, Dr. Andrew Klapper, brings his more than ten years of experience and revolutionary surgical techniques, along with the most advanced 3D imaging technology available to his new Staten Island medical practice, Staten Island Special Surgery.

30 Mar 2010

Chromatin expands operations to 5,000 square foot facility in University of Illinois' Research Park

The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.

30 Mar 2010

Technology News and Research

CryoLife files emergency motion for preliminary injunction against Medafor

FDA grants priority review status for Isotechnika Pharma's voclosporin

Reverse Medical closes Series-B private equity financing

QRxPharma initiates Phase 1 trial for evaluating PK profiles of morphine, oxycodone CR formulations

Vision CRC scientists discover new technology to control myopia

Access Pharmaceuticals, bioRASI sign collaborative agreement to develop Cobalamin oral insulin product

Hospira acquires Orchid's injectables formulations business

CLC bio signs partnership agreement with Ion Torrent

Ascent Therapeutics is now Anchor Therapeutics

Campbell Soup honored for commitment to food allergy safety, awareness and education

Investment report on Fonar from InvestorSoup.com

USPTO issues patent for Incisive Surgical's proprietary INSORB Absorbable Skin Stapling Technology

Bayshore Home Health deploys WinMagic's SecureDoc full-disk encryption software

MedBuild receives MBI's 2010 Awards of Distinction for Nash Memorial Hospital Project

Ohio Board of Pharmacy approves CPSI's CPOE, E-MAR and Pharmacy applications

Study suggests two distinct versions of multiple sclerosis

Irvine Scientific's Vit Kit- Freeze, Vit Kit- Thaw and Oil for Embryo Culture receive CE mark approval

A-Life Medical renews extensive contract for CAC services with Associated Billing Services

VECTRA X3 3D Imaging System now available at Staten Island Special Surgery

Chromatin expands operations to 5,000 square foot facility in University of Illinois' Research Park

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News